Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,189 | 428 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $745.19 | 57 | $0 (2024) |
| Lilly USA, LLC | $665.72 | 52 | $0 (2024) |
| PFIZER INC. | $640.08 | 65 | $0 (2024) |
| ABBVIE INC. | $580.65 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $420.97 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $360.03 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $346.93 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $207.17 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $189.16 | 13 | $0 (2024) |
| Amgen Inc. | $188.15 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,158 | 59 | Lilly USA, LLC ($171.87) |
| 2023 | $908.62 | 53 | AbbVie Inc. ($193.59) |
| 2022 | $999.26 | 62 | ABBVIE INC. ($194.64) |
| 2021 | $39.77 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.27) |
| 2020 | $140.72 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($30.64) |
| 2019 | $745.10 | 60 | Novo Nordisk Inc ($150.89) |
| 2018 | $893.00 | 73 | PFIZER INC. ($168.60) |
| 2017 | $1,304 | 109 | PFIZER INC. ($206.62) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Oncology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: VACCINE | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Biological | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/01/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: VACCINE | ||||||
| 07/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 591 | 888 | $132,795 | $33,170 |
| 2022 | 12 | 645 | 1,031 | $145,049 | $38,100 |
| 2021 | 13 | 700 | 1,071 | $133,775 | $74,350 |
| 2020 | 14 | 732 | 1,067 | $120,110 | $58,797 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 417 | $72,975 | $13,525 | 18.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 140 | 140 | $28,420 | $6,208 | 21.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 16 | $10,640 | $4,517 | 42.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 61 | 61 | $4,087 | $3,940 | 96.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 72 | $9,056 | $2,010 | 22.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $2,775 | $1,850 | 66.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 16 | $704.00 | $469.76 | 66.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 49 | $2,496 | $410.03 | 16.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 20 | $1,440 | $210.52 | 14.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 34 | $201.79 | $31.10 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 203 | 483 | $79,695 | $16,583 | 20.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 139 | 139 | $28,217 | $6,708 | 23.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 61 | 61 | $4,087 | $3,940 | 96.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $8,645 | $3,578 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 76 | $9,744 | $2,803 | 28.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 64 | 66 | $2,904 | $1,818 | 62.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $5,112 | $1,145 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 72 | $3,741 | $735.90 | 19.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $836.00 | $538.14 | 64.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $1,152 | $145.02 | 12.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 20 | 57 | $627.00 | $70.70 | 11.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $289.00 | $35.39 | 12.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 174 | 423 | $66,411 | $36,765 | 55.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 127 | 127 | $25,781 | $16,574 | 64.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 103 | $10,918 | $5,702 | 52.2% |
About Dr. Michelle Riley, DO
Dr. Michelle Riley, DO is a Internal Medicine healthcare provider based in Avon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952370090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Riley, DO has received a total of $6,189 in payments from pharmaceutical and medical device companies, with $1,158 received in 2024. These payments were reported across 428 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($6,189).
As a Medicare-enrolled provider, Riley has provided services to 2,668 Medicare beneficiaries, totaling 4,057 services with total Medicare billing of $204,416. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Avon, OH
- Active Since 03/14/2006
- Last Updated 12/08/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952370090
Products in Payments
- JARDIANCE (Drug) $336.94
- Ozempic (Drug) $292.42
- MOUNJARO (Drug) $285.48
- VRAYLAR (Drug) $267.11
- CHANTIX (Drug) $263.71
- UBRELVY (Drug) $204.80
- TRULICITY (Drug) $196.49
- NURTEC ODT (Drug) $155.01
- Cologuard Collection Kit (Device) $154.69
- Otezla (Drug) $135.96
- AIRSUPRA (Drug) $128.84
- Victoza (Drug) $105.62
- BYDUREON (Drug) $103.54
- VIAGRA (Drug) $99.48
- LEQVIO (Drug) $94.93
- ELIQUIS (Drug) $93.86
- Saxenda (Drug) $92.74
- SOLIQUA (Drug) $83.39
- XARELTO (Drug) $82.88
- GARDASIL (Biological) $79.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Avon
Dr. Monica Grafals, M.d, M.D
Internal Medicine — Payments: $498,418
Ingrid Grafals, Md, MD
Internal Medicine — Payments: $13,888
Dr. Sheila Rice, M.d, M.D
Internal Medicine — Payments: $13,874
Dr. Xiusheng Qin, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $11,247
Namrata Shah, Md, MD
Internal Medicine — Payments: $10,414
Dr. Andrew Filiatraut, Do, DO
Internal Medicine — Payments: $10,250